Biotech Co.*
(Country;
Symbol)

Pharma Co.
(Country)

Product

Terms/Details (Date)


Accelrys
Inc.*

Sigma-Aldrich Corp.

Deal to integrate Sigma- Aldrich chemical compound catalogues into Accelrys' chemical suppliers database

Terms of the deal were not disclosed (9/29)

Aerogen Inc.
(AEGN)

Respironics Inc.

Respironics will distribute the Aeroneb Pro nebulizer system

Respironics will use the system with its new and existing ventilator support systems under a worldwide, nonexclusive license (10/5)

Avanir
Pharmaceuticals
Inc.
(AMEX:AVN)

ACO Hud (Sweden)

ACO Hud got rights to make and sell docosanol 10% cream for cold sores in Scandinavia

Avanir gets a license fee, royalties on sales and milestones related to approvals in Norway, Denmark and Finland (it's approved in Sweden) (10/5)

Cellomics Inc.

Shanghai AnXing Scientific Instrument & Materials Import & Export Co. Ltd. (China)

AnXing will be the distribution partner for Cellomics in China

AnXing will provide sales, marketing, service and customer support for Cellomics products under undisclosed terms (9/8)

Cyntellect Inc.*

SC Biosciences (Japan)

SCB will help market Cyntellect's cell line development service in Japan

SCB will be the limited exclusive marketing partner for Cell Xpress service under undisclosed terms (9/30)

Epoch Biosciences Inc. (EBIO)

Cambrex Corp.

Cambrex will incorporate Epoch's MGB Eclipse probe technology into its microbial detection products and services

Epoch gets an up-front payment, revenues from shipments of probes and primers to Cambrex, royalties on sales and services, and revenue for optimization work (10/14)

Genentech
Inc.
(NYSE:DNA)

Wyeth

Manufacturing agreement for Genentech's approved product Herceptin

Wyeth will manufacture the cancer drug under undisclosed terms (9/23)

Guava
Technologies
Inc.*

GE Healthcare (UK)

They expanded distribution deal for Guava's cell analysis system and reagents

The deal, previously covering Japan, was expanded to include South Korea, Mexico and certain Latin America and Caribbean countries (9/29)

Hemosol Corp.
(Canada; HMSL)

Organon Canada (division of Akzo Nobel; the Netherlands)

Hemosol will manufacture and supply Organon's licensed heparin product Hepalean in Canada

Terms of the three-year deal were not disclosed (9/28)

Labopharm Inc. (Canada; TSE:DDS)

Hexal AG (Germany)

Hexal will market and sell Labopharm's once-daily formulation of tramadol in Germany

Labopharm would receive payments for achieving certain milestones through to regulatory approval, and would share revenue from product sales; it is responsible for obtaining approval in Germany (9/15)

Large Scale
Biology Corp.
(LSBC)

PerkinElmer Inc.

Co-marketing agreement on biomarker discovery technology

The technology, from Large Scale subsidiary Predictive Diagnostics Inc., will be used with PerkinElmer mass spectrometers; terms were not disclosed (9/13)

Samaritan
Pharmaceuticals
Inc.
(AMEX:LIV)

Pharmaplaz (Ireland)

Pharmaplaz will help with Samaritan's pipeline development, scale-up and manufacturing requirements

The deal includes Samaritan's lead compound SP-01A and the rest of its pipeline, and work on gaining FDA approvals; terms were not disclosed (10/5)

Santarus Inc.
(SNTS)

Otsuka America Pharmaceutical Inc.

Five-year co-promotion deal covering Santarus' gastro-intestinal product Zegerid (omeprazole) in the U.S.

The deal includes options to extend the deal to cover capsule and chewable tablet formulations (10/6)

VioQuest Pharmaceuticals Inc. (OTC BB:VQPH)

Pfizer Inc.

Pfizer is using VioQuest ligand technology for process development and manufacture of therapeutic compounds

Pfizer entered the deal with VioQuest subsidiary Chiral Quest Inc.; terms were not disclosed (10/20)

Xenova
Group plc
(UK; XNVA)

QSV Biologics Ltd. (Canada)

QSV purchased Xenova's manufacturing facility in Edmonton, Alberta, for C$7M (US$5.4M)

They also reached agremeent for manufacturing of Xenova's TransMID, a product in Phase III trials for high-grade glioma (9/3)


Notes:

# The information in the chart does not cover agricultural agreements or those between biotech companies.

* Private companies are indicated with an asterisk.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

AMEX = American Stock Exchange; NYSE = New York Stock Exchange; OTC BB = Over-the-Counter Bulletin Board; TSE = Toronto Stock Exchange.